objective We report the first national programme in Côte d'Ivoire to evaluate the feasibility of nurse-led HIV care as a model of task-sharing with nurses to increase coverage and decentralisation of HIV services.
Introduction
Since 2006, WHO has recommended task-sharing of HIV care and treatment with nurses in resource-limited settings which have a paucity of physicians as an approach to reduce the effect of human resource shortages and enable scale-up and decentralisation of HIV services to reach those who need these services [1] .
Several studies conducted in Africa have reported that nurse-led HIV care led to a similar quality of care compared with physician-led care and was cost-effective [2] [3] [4] [5] [6] [7] [8] . The majority of these studies were reported from countries in Southern and East Africa with comparatively limited data reported from West Africa, a region with a different HIV epidemic and a distinct health system structure [4, [9] [10] [11] .
Côte d'Ivoire has the highest HIV prevalence in West Africa with a national prevalence of 3.7%, and a healthcare provider ratio of one physician and five nurses/midwives per 10 000 persons [12, 13] . In 2011, only 41% of adults and 15% of children who were eligible for antiretroviral therapy (ART) received it. At that time, and largely reflecting a traditionally physician-focused health delivery system, only physicians were allowed to initiate ART and provide follow-up HIV care, which included clinical assessment, monitoring of side effects and adherence, and prescription refills. However, physicians were primarily based in larger secondary/tertiary health facilities and visited the primary health facilities associated with the larger facilities on varying schedules. In the context of HIV services, the nursing scope of work was limited to HIV counselling and testing. Thus, the paucity of physicians and limited scope of work for nurses regarding HIV services has contributed to the low numbers of patients initiating ART and treatment delays in the smaller, often rural, facilities.
In February 2012, a pilot programme of nurse-led HIV care and treatment for adults and children was initiated to evaluate the feasibility of two models of nurse-led HIV care, one with 'a nurse with and an on-site physician' and the second with 'a nurse with a visiting physician'. We report on the feasibility and clinic-level outcomes, including retention, lost to follow-up and death, in this pilot project.
Methods

Setting and study design
Twenty-six facilities were selected by the Ivorian Ministry of Health based on having existing HIV testing and counselling activities with a minimum of 20 HIV-infected patients enrolled in HIV care in the six months prior to pilot study implementation. The pilot programme was designed with a 1-month training period followed by a 12-month implementation phase. Nurses implemented pilot activities at selected health facilities with two different models of HIV care, depending on the availability of an on-site physician at each facility. The first model, termed 'nurse with on-site physician', involves availability of supervision and mentorship by a physician who worked on site with the nurse at all times. The second model, termed 'nurse with visiting physicians', refers to nurses working independently at a facility with a supervising physician visiting the facility on a weekly or twicea-week basis to provide mentorship and review cases. The latter reflected settings with no physicians on site. In this model, nurses were allowed to initiate ART among eligible patients any day and reviewed cases with a physician during physician visits. For this pilot, the Ministry formally expanded the nursing scope of practice to allow nurses to initiate and manage eligible patients on ART.
The pilot programme was conducted by Ministry of Health staff with technical assistance from ICAP at Columbia University. A technical working group composed of Ministry of Health representatives, and implementing partners was responsible for defining the nurses' scope of work related to ART initiation and management, selection of pilot facilities, and oversight of programme implementation.
Training and mentorship
Topics covered in nurse training for HIV management and ART initiation included general HIV knowledge, ART initiation of first-line regimens, monitoring of drug side effects, referral of cases to physicians at higher-level facilities, care and support services, and use of Ministry of Health HIV registers and reporting tools [14, 15] . Nurses, who were providing clinical care at pilot facilities and had bachelor of science in nursing, received a oneweek clinical training on the above topics, and physicians also received a one-week training on mentoring techniques and supervision processes. Physicians provided intensive mentorship for the first month of the pilot which included once-a-week on-site mentorship to each nurse. Mentorship focused on physical examination skills, reviewing laboratory results, selecting appropriate regimens for eligible patients, filling care and treatment data tools, documenting the ART initiation appointment and what side effects to anticipate based on the prescribed ART regimen and how to recognise immune reconstitution syndrome. At the end of this month, nurses were observed by a physician on their history taking, clinical examination, use of ART eligibility criteria and patient documentation procedures skills. Nurses who passed this observation period were allowed to initiate ART independently and those who did not received a second month of mentorship. Mentorship continued over the entire period of the pilot project and consisted of physicians providing on-site mentorship once a month. Nurses could also consult the physician by phone as needed.
HIV care and treatment
Provision of ART and follow-up care followed national and WHO guidelines [16, 17] . Prior to 2012, children < 12 months who had CD4% <25%, children 12-35 months with CD4% <20, and children >36 months with CD4% <15% (or any child with WHO stage III or IV disease regardless of age) were eligible for ART. After October 2012, all children <2 years initiated ART. ART was recommended for adults aged >15 years with CD4 count ≤200 cells/ll prior to October 2012 and ≤350 cells/ ll after October 2012, or WHO stage III or IV disease. Tenofovir-based regimens became first-line treatment in 2010. The first-line ART regimen for children was zidovudine, lamivudine and nevirapine. CD4 counts were performed at time of ART initiation and every six months thereafter; viral load was not routinely measured. Eligible patients received counselling sessions on ART readiness prior to ART initiation. Follow-up appointments were recommended every month. Patients not eligible for ART were followed every 3 months. Nurses used the patient registers and files approved by the national programme. Retention in care and adherence to ART were encouraged by peer counselling and social support programmes.
Data collection and statistical analysis
A prospective cohort analysis was performed using monthly aggregate data, which were routinely reported on patients enrolled in care and who initiated ART using national forms to the Ministry of Health from January and April 2012 (due to a phased start) and through the follow-up period of 10-14 months, which was dependent on the duration of the pilot in each facility. Data were not reported on pre-ART outcomes.
Data from patients newly enrolled in HIV care and having treatment initiated by nurses were included in the monthly activity report. Patients who were enrolled into care at the facility before the study period or who were initiated at another facility and transferred into a pilot facility were excluded from this analysis. Routinely reported data included: number of patients enrolled into care, number of patients who initiated ART, number of patients with CD4+ count in the strata of <200, 200-350 or >350 cells/ll at enrolment in care, and ART patient outcome status including alive in care, lost to follow-up, death and transfer. Loss to follow-up was defined as no facility visit for 90 days from last facility visit. Information on deaths and transfers were abstracted from facility records. CD4+ count at enrolment in care and outcome status among ART patients were reported by sex, age group, facility type and model of care.
Facility and patient characteristics were assessed at the time of enrolment in HIV care. We compared CD4+ counts at time of enrolment in HIV care and patient outcomes (documented transfers out, deaths, loss to followup and retention) among those who initiated ART by sex, age, facility type and model of care using chi-squared tests and Fisher's exact tests. We also compared the number and proportion of patients who initiated ART over time at facilities with the two models of care. A multivariable model of facility-level retention in care across the 26 facilities was performed using a Poisson regression model with generalised estimated equations, accounting for repeated measures within facilities and treating facility age as continuous time measures, including the proportion of patients female per facility, the proportion of patients with CD4+ count < 200 cells/ll per facility, and model of care in each facility. Given model of care was collinear with facility type (i.e. primary vs. secondary/tertiary), only model of care was included in the multivariable model. Data from two facilities with <10 months of data were excluded from trend analysis. All analyses were conducted using SAS Version 9.3 (Cary, NC, USA).
Ethics approval
The Comite National de l'Ethique et de la Recherche in Côte d'Ivoire and Columbia University's institutional review board, as well as the US Centers for Disease Control and Prevention Human Subjects Office, approved this programme.
Results
Facility and nurse characteristics
Twenty-six facilities participated in this pilot programme including 20 primary health facilities, four secondary health facilities and two tertiary health facilities (Figure 1 , Table S1 ). Fourteen facilities (54%) were located in rural areas, and 20 (77%) were primary health facilities (Table 1) . A total of 74 nurses were trained to provide HIV care and treatment with 66 (89%) passing national training requirements and participating in programme activities. Twelve facilities (46%) utilised the nurse-with-on-site-physician model of care, including all six of the secondary/tertiary facilities and six of the 12 primary health facilities. A total of 14 (54%) facilities, all of which were primary level, utilised the nurse-withvisiting-physician model of care. Seven of the 12 facilities with on-site physicians had more than two physicians. Fourteen facilities (54%) had more than two nurses per facility. All 14 facilities with a nurse-with-visiting-physician model of care had less than five nurses per facility as compared to seven of the facilities with nurse-with-onsite physician have greater than five nurses per facility (P = 0.0016). Fourteen facilities (54%) began providing ART initiation for the first time in 2012 during the pilot programme. Twenty-four facilities had 10-14 months of pilot activities with available data for analysis. Two facilities terminated participation in the pilot programme because the trained nurses had left the facility (one at 4 months and one at 7 months after the pilot programme began). Both of these facilities had an on-site-physician model of care.
Patient characteristics
A total of 1224 patients were enrolled in HIV care by a nurse across all facilities from January 2012 through May 2013 ( Table 2 ). The majority of patients (94%) were adults, had HIV-1 infection (87%) and were female (79%). A total of 89 patients (7%) had HIV-2 infection. A CD4+ count at time of enrolment in HIV care was recorded for 1171 (96%) patients, with 508 adults (44%) and 40 children (22%) having a CD4+ count >350 cells/ll (Table 3) .
A total of 804 patients (66%) enrolled in care at one of the 20 primary health facilities, and 766 (63%) enrolled in care at a facility with a nurse-with-on-site-physician model of care. A total of 666 patients (55% of all patients who enrolled in care) initiated ART during the follow-up period. The majority of those who initiated ART were adults (93%) and female (77%). A total of 407 patients (61%) initiated ART at primary health facilities and 439 (66%) initiated at facilities with a nurse-with-on-site-physician model. Conversely, the majority of children initiated ART at secondary/tertiary health facilities (n = 28/ 46, 61%) and consequently a higher proportion initiated at facilities with a nurse-with-on-site-physician model (n = 38/46, 83%) (data not shown).
CD4+ count at enrolment in HIV care
Among women, a significantly higher proportion (46%) had a CD4+ count >350 cells/ll than men (39%) (P = 0.0247) ( Table 3) . A significantly higher proportion of patients with a CD4+ count >350 cells/ll were seen at primary facilities than at secondary/tertiary facilities (49% vs. 36%, P < 0.0001) and at facilities with a nurse-with-visiting-physician model of care vs. those with a nurse-with-on-site-physician model of care (52% vs. 41%, P = 0.0002). In addition, a significantly higher proportion of adults than children had a CD4+ count <200 cells/ll with 29% vs. 11.6%, respectively (P = 0.0018). Table 4 shows outcomes among all patients (n = 666) who initiated ART at the participating facilities, 439 (66%) at facilities with nurses with on-site physicians and 227 (34%) at facilities with nurses with visiting physicians. Over the pilot period, a total of 567 patients (85%) on ART were retained in care, 28 (4%) died, 47 (7%) were lost to follow-up, and 24 (4%) transferred HIV care to another facility. Five deaths among children and 23 among adults were recorded (11% vs. 4%, respectively, P = 0.0372). A significantly higher proportion of patients were retained in primary health facilities as compared to secondary/tertiary facilities (86% vs. 80%, P = 0.0026). Also, a significantly higher proportion of patients from facilities with a visiting physician as compared to an on-site-physician model of care were retained in care (90% vs. 83%, P = 0.0136), with 2.6% vs. 9.3% lost to follow-up (P = 0.0014), respectively. However, when controlling for proportion of patients who were female and proportion of patients with CD4+ count <200 at enrolment in care, there were no differences in retention across facilities by model of care (Risk Ratio 0.98, 95% CI 0.74-1.30) ( Table 5) . Figure 2 shows the number and proportion of patients who initiated ART by the model of care at 24 facilities which had at least 10 months of participation in the pilot programme. The number of patients who initiated ART at facilities with visiting physicians ranged from 11 to 25 per month (median number 1-2 patients per facility per month) over the follow-up period with no evidence of an increased trend observed over time (P = 0.509). The number of patients who initiated ART at facilities with on-site physicians ranged from 24 to 41 per month (median number 1-2 patients per facility per month), also with no increased trend observed over time (P = 0.736). During the first month of the pilot project, an approximately equal proportion of patients initiated ART at facilities with the two models of care -49% at facilities with visiting physicians as compared to 51% with onsite physicians. By month 10, 73% of all patients who initiated ART were at facilities with on-site physicians, consistent with the larger number of patients enrolled in care at these facilities.
Outcomes of patients who initiated ART
Discussion
In this analysis, we found that task-sharing of HIV care, including ART initiation, with nurses is feasible in Côte d'Ivoire in a pilot programme that included two models of care, one in which nurses initiated and managed patients on ART at facilities with on-site physicians compared with one with nurses who worked independently with support from visiting physicians. Overall, 666 patients were initiated on ART across 26 participating facilities; there were very few paediatric ART initiations. Patient retention across all facilities was high at 85%, with no significant differences across the facilities. There was no observed increase in median number of patients initiating ART at facilities by model of care over time, and the majority of patients initiated ART at tertiary/secondary facilities with on-site physicians which had larger number of patients enrolled in care. This study adds important information to the growing literature supporting task-sharing of HIV care and ART initiation among physicians and nurses that enabled the rapid scale-up of access to ART to over 12 million persons in sub-Saharan Africa [4, 18] . West Africa in general, and specifically Côte d'Ivoire, has lagged behind in scale-up of access to ART and in implementing task-sharing [19] . Côte d'Ivoire has a profound shortage of healthcare providers, and task-sharing HIV management could expand decentralisation and scale-up of HIV services nationally [20] . This study adds to another study of tasksharing of HIV care and treatment from Cameroon that found no differences among a cohort of 459 HIV-infected adults in terms of virological success, CD4 recovery and disease progression in HIV patients who were clinically cared for by physicians vs. nurses [10] .
Overall, there was high (85%) retention of patients who initiated ART during this pilot programme. This rate is similar to a prior report from Côte d'Ivoire with the 12-month retention rate among 3682 adults who initiated treatment, with physician-led care, at 24 health facilities ranging from 69% to 86% [21] . While this pilot study was not powered to detect differences in retention across facility-level factors, univariate analysis suggests the potential of lower loss to follow-up in primary health facilities as compared to secondary/tertiary facilities, which is similar to findings from other studies in Africa.
A study analysing retrospective data in South Africa reported higher retention in primary health facilities as compared to district and regional hospitals [22] . A study in Ethiopia reported that loss to follow-up among HIVinfected adults on ART was lower in health centres as compared to hospitals [23] . Lower loss to follow-up rates among children receiving care at primary health facilities, as compared to secondary facilities, has also been previously reported from a study conducted in Kenya, Lesotho, Mozambique, Rwanda and Tanzania [24] . Reasons for lower lost to follow-up at primary centres may include other clinic-level factors such as increased convenience, short wait times and decreased transport costs. In this analysis, we are unable to assess for differences in patient-level characteristics across facility type due to lack of patient-level data.
While nurses who participated in this pilot were trained to provide HIV care to paediatric patients, few children (n = 46) initiated ART during the pilot period, and the majority of paediatric ART initiations occurred in secondary-level facilities with a model of care of nurses with on-site physicians (83%). This finding is consistent with historical data reporting a disproportionately smaller number of children as compared to adults receiving HIV care and treatment in Côte d'Ivoire. In 2013, only 16% of an estimated 35 000 ART-eligible children P-values were calculated using chi-squared tests and Fisher's exact tests. received ART, whereas 55% of the estimated 190 000 ART-eligible adults did [25] [26] [27] . Historically, paediatric HIV care has been restricted to higher-level facilities with trained paediatric specialists so it may require further efforts to enable scale-up of paediatric HIV services at lower-level health facilities and by nurses. However, the small number of children who initiated treatment in this project may reflect a failure to identify HIV-infected children and to initiate ART among those known to be HIV-infected.
In this analysis, a high proportion of paediatric patients died (11%), which is similar to the 12-month mortality rate (3-11% from 2004 to 2008) reported in a retrospective analyses of 2000 HIV-infected paediatric outcomes in Côte d'Ivoire [25] . Interestingly, the proportion of children who were lost to follow-up was roughly half of the proportion who had died, which differs from a large study of paediatric ART outcomes from 2004 to 2007 in Côte d'Ivoire in which reported lost to programme rates were nearly double the mortality rates [28] . This finding may be due to a shorter follow-up time in these analyses or improvements in the documentation of deaths.
A unique aspect of this study is the use and evaluation of two models of nurse-provided HIV care and treatment. The two models reflect the availability of physicians for nurse mentorship at primary vs. secondary/tertiary facilities and Côte d'Ivoire is likely to require implementation of both models in order to fit the workforce characteristics at the different types of health facilities. For example, the nurse-with-visiting-physician model allows for provision of HIV care and treatment at facilities which previously did not provide ART or did not provide such services on a consistent basis. The model of nurse with on-site physician may allow for increased coverage at the tertiary and secondary facilities with large patient loads and may allow for rapid provision of services to patients to avoid lengthy waiting times to be seen by physicians. Given all secondary/tertiary facilities in this pilot provided nurse-with-onsite-physician model of care, differences of clinic-level outcomes by model of care cannot be differentiated from differences in clinic level. One important goal of the pilot programme was to decentralise ART to nurse-led primary-level facilities, which have a nurse-with-visiting-physician model of care. Indeed, 14 of the primary-level facilities were enabled to initiate ART due to this model of task-sharing; however, the majority of patients who initiated ART continued to be at facilities with onsite physicians, many of which already had capacity, albeit via physicians only, to initiate ART. This may reflect the fact that there were more patients eligible for ART at the larger facilities with onsite physicians, poorer identification of eligible patients at lower-level facilities with visiting doctors, and/or a pilot start-up learning curve. In addition, we did not observe an increase in the median number of patients who initiated ART per month per facility in either model of care. This highlights the need to expand HIV testing at lower facilities to identify more patients with HIV infection and thus enhance coverage for HIV-infected patients. Importantly, the demonstration of the feasibility of nurses to provide ART care independently with visiting physicians allows for consideration of decompression of crowded higher-level facilities to lower-level facilities without any evidence of sacrificed quality of follow-up.
The study has several strengths. The patient population included all patients who received HIV care and treatment during the pilot period at the selected sites. It compared two pragmatic implementation approaches to providing nurse-led HIV care and ART initiation in a resource-constrained setting in Western Africa. Additionally, the characteristics of adult patients receiving nurseled HIV care in this analysis appear similar to characteristics reported in adult cohorts prior to task-sharing in Côte d'Ivoire, suggesting that the pilot included patients generalisable to the national community of persons living with HIV [21] .
The study also has limitations. It included a small number of children and, thus, the findings may not be generalisable to other HIV programmes with larger paediatric populations. The study used routinely collected aggregate data to measure the outcomes of interest and, thus, suffers the limitations inherent in use of such data. This includes the issue of missing data and the limited ability to assess for the association of individual characteristics such as sex, age and CD4+ count with retention, lost to follow-up and death. There is also the likelihood of misclassification of patients as some outcomes such as loss to follow-up are complex to ascertain in large HIV programmes. For example, on attempting tracing individuals who were noted as lost to follow-up, it has been noted that a substantial proportion of them had either died or transferred care to another health facility [29] . Nevertheless, this study provides additional data to support the feasibility and benefits of task-sharing of HIV care and treatment with nurses in HIV programmes in West Africa, a region where such an approach has not been widely adopted [10, 11] .
Conclusions
Given the paucity of data on task-sharing of HIV services in West Africa, this analysis provides important information on the feasibility of task-sharing of HIV care in Côte d'Ivoire, which may be relevant to other countries in West Africa. Through a national pilot programme, a total of 26 facilities implemented nurse-led HIV care and ART initiation for both children and adults across a spread of disease severity. Two models of task-sharing are identified including a model where nurses are supported by on-site physicians and another with visiting physicians -both of which are likely needed for national scale-up of ART initiation. Patient outcomes were reassuring across facilities participating in the pilot. Further analyses using longitudinal cohort data are needed to elucidate patient and facility characteristics associated with outcomes.
